Congressional Research Service Reports - 24 Matching Results

Search Results

Results: 1 - 24
open access

Title X (Public Health Service Act) Family Planning Program

Description: This report looks at several bills addressing the Family Planning Program (Title X of the Public Health Service Act) which have been introduced in the 112th Congress, including: funding for abortion-providing entities, elimination of the program, and prohibitions on government spending for the program.
Date: September 3, 2014
Creator: Napili, Angela
Partner: UNT Libraries Government Documents Department
open access

Suicide Prevention Efforts of the Veterans Health Administration

Description: Responsibility for prevention of veteran suicide lies primarily with the Veterans Health Administration (VHA), within the Department of Veterans Affairs (VA). The VHA Strategic Plan for Suicide Prevention is based on a public health framework, which has three major components: (1) surveillance, (2) risk and protective factors, and (3) prevention interventions. This report identifies challenges the VHA faces in each component of suicide prevention and discusses potential issues for Congress.
Date: February 3, 2012
Creator: Bagalman, Erin
Partner: UNT Libraries Government Documents Department
open access

Follow-On Biologics: Intellectual Property and Innovation Issues

Description: This report reviews doctrinal and policy issues pertaining to follow-on biologics. The report first introduces the application of federal food and drug legislation to follow-on biologics. It next turns to the patent implications of marketing follow-on biologics. Following this review of substantive law, the remainder of the report introduces innovation policy issues pertaining to follow-on biologics.
Date: August 3, 2009
Creator: Schacht, Wendy H. & Thomas, John R.
Partner: UNT Libraries Government Documents Department
open access

Federal R&D, Drug Discovery, and Pricing: Insights from the NIH-University-Industry Relationship

Description: This report explores the reasons behind government funding of research and development and subsequent efforts to facilitate private sector commercialization of the results of such work, without addressing issues associated with drug costs or pricing. It particularly looks at the manner in which the National Institutes of Health (NIH) supports research to encourage the development of new pharmaceuticals and therapeutics, particularly through cooperative activities among academia, industry, and g… more
Date: February 3, 2009
Creator: Schacht, Wendy H.
Partner: UNT Libraries Government Documents Department
open access

HIV/AIDS International Programs: Appropriations, FY2003-FY2006

Description: This report briefly discusses appropriations for international HIV/AIDS programs. FY2006 Appropriations for Foreign Operations (P.L. 109-102), Labor/HHS/Education (H.Rept. 109-300), Defense, and Agriculture (P.L. 109-97) provide more than $3.4 billion for international HIV/AIDS, tuberculosis (TB), and malaria initiatives. The largest portion of the funds is provided through P.L. 109-102, which directs more than $2.8 billion to fighting the three diseases.
Date: January 3, 2006
Creator: Salaam-Blyther, Tiaji
Partner: UNT Libraries Government Documents Department
open access

The Global Fund and PEPFAR in U.S. International AIDS Policy

Description: The international HIV/AIDS pandemic continues to deepen. According to UNAIDS, the Joint United Nations Program on HIV/AIDS, an estimated 39.4 million people were living with HIV in 2004, including 4.9 million who were newly infected during the year. This report discusses the President’s Emergency Plan for AIDS Relief (PEPFAR), which includes bilateral programs and contributions to the multilateral Global Fund for AIDS, Tuberculosis, and Malaria.
Date: November 3, 2005
Creator: Copson, Raymond W.
Partner: UNT Libraries Government Documents Department
open access

The Virus-Serum-Toxin Act: A Brief History and Analysis

Description: The Viruses, Serums, Toxins, Antitoxins, and Analogous Products Act (21 U.S.C. 151-159), also known as the Virus-Serum-Toxin Act (VSTA), is intended to assure the safe and effective supply of animal vaccines and other biological products. The act and its applicable regulations are administered by the Animal and Plant Health Inspection Service (APHIS) of the United States Department of Agriculture (USDA).
Date: January 3, 2005
Creator: Monke, Jim
Partner: UNT Libraries Government Documents Department
open access

The Virus-Serum-Toxin Act: A Brief History and Analysis

Description: The Viruses, Serums, Toxins, Antitoxins, and Analogous Products Act (21 U.S.C. 151-159), also known as the Virus-Serum-Toxin Act (VSTA), is intended to assure the safe and effective supply of animal vaccines and other biological products. The act and its applicable regulations are administered by the Animal and Plant Health Inspection Service (APHIS) of the United States Department of Agriculture (USDA).
Date: January 3, 2005
Creator: Monke, Jim
Partner: UNT Libraries Government Documents Department
open access

FDA Regulation of Tobacco Products: A Policy and Legal Analysis

Description: This report examines the legislative debate over giving FDA the authority to regulate tobacco products and provides some analysis of S. 2461/H.R. 4433. It begins with an overview of the FDA’s 1996 tobacco rule that includes a summary of the agency’s arguments for asserting jurisdiction over tobacco products. That is followed by an analysis of the U.S. Supreme Court decision in FDA v. Brown & Williamson, which overturned the FDA tobacco rule. The report then reviews the 1997 proposed national to… more
Date: December 3, 2004
Creator: Redhead, C. Stephen & Feder, Jody
Partner: UNT Libraries Government Documents Department
open access

The Private Testing of Mad Cow Disease: Legal Issues

Description: This report provides information on how most of the countries banned United States beef after a single report of Bovine Spongiform Encephalopathy (BSE) in a Canadian-born cow after the December 2003 U.S. report. Creekstone Farms Premium Beef, proposed to conduct BSE rapid tests to be able to do exports, but USDA rejected this proposal since it implies as consumer safety rather than animal health. Updated December 3, 2004.
Date: December 3, 2004
Creator: Vina, Stephen R
Partner: UNT Libraries Government Documents Department
open access

The Private Testing of Mad Cow Disease: Legal Issues

Description: This report provides information on how most of the countries banned United States beef after a single report of Bovine Spongiform Encephalopathy (BSE) in a Canadian-born cow after the December 2003 U.S. report. Creekstone Farms Premium Beef, proposed to conduct BSE rapid tests to be able to do exports, but USDA rejected this proposal since it implies as consumer safety rather than animal health. Updated December 3, 2004.
Date: December 3, 2004
Creator: Vina, Stephen R
Partner: UNT Libraries Government Documents Department
open access

AIDS in Africa

Description: Sub-Saharan Africa has been far more severely affected by AIDS than any other part of the world. The United Nations reports that 29.4 million adults and children are infected with the HIV virus in the region, which has about 10% of the world's population but more than 70% of the worldwide total of infected people. This report discusses this issue in detail, including the cause of the African AIDS epidemic, the social and economic consequences, response and treatment, and U.S. policy.
Date: October 3, 2003
Creator: Copson, Raymond W.
Partner: UNT Libraries Government Documents Department
open access

AIDS in Africa

Description: Sub-Saharan Africa has been far more severely affected by AIDS than any other part of the world. The United Nations reports that 25.3 million adults and children are infected with the HIV virus in the region, which has about 10% of the world's population but more than 70% of the worldwide total of infected people. This report discusses this issue in detail, including the cause of the African AIDS epidemic, the social and economic consequences, response and treatment, and U.S. policy.
Date: March 3, 2003
Creator: Copson, Raymond W.
Partner: UNT Libraries Government Documents Department
open access

Medical Records Privacy: Questions and Answers on the HIPAA Final Rule

Description: This report discusses the issue facing Congress on whether to continue to support the executive branch’s prosecution of medical marijuana patients and their providers, in accordance with marijuana’s status as a Schedule I drug under the Controlled Substances Act, or whether to relax federal marijuana prohibition enough to permit the medical use of botanical cannabis products by seriously ill persons, especially in states that have created medical marijuana programs under state law.
Date: January 3, 2003
Creator: Redhead, C. Stephen
Partner: UNT Libraries Government Documents Department
open access

Medical Records Privacy: Questions and Answers on the HIPAA Final Rule

Description: This report discusses the issue facing Congress on whether to continue to support the executive branch’s prosecution of medical marijuana patients and their providers, in accordance with marijuana’s status as a Schedule I drug under the Controlled Substances Act, or whether to relax federal marijuana prohibition enough to permit the medical use of botanical cannabis products by seriously ill persons, especially in states that have created medical marijuana programs under state law.
Date: October 3, 2002
Creator: Redhead, C. Stephen
Partner: UNT Libraries Government Documents Department
Back to Top of Screen